PLXDC1 Antibody (monoclonal) (M01)
Mouse monoclonal antibody raised against a partial recombinant PLXDC1.
- 产品详情
- 实验流程
Application ![]()
| WB, E |
---|---|
Primary Accession | Q8IUK5 |
Other Accession | NM_020405 |
Reactivity | Human |
Host | mouse |
Clonality | monoclonal |
Isotype | IgG2b Kappa |
Clone Names | 4B10 |
Calculated MW | 55760 Da |
Gene ID | 57125 |
---|---|
Other Names | Plexin domain-containing protein 1, Tumor endothelial marker 3, Tumor endothelial marker 7, PLXDC1, TEM3, TEM7 |
Target/Specificity | PLXDC1 (NP_065138, 313 a.a. ~ 421 a.a) partial recombinant protein with GST tag. MW of the GST tag alone is 26 KDa. |
Dilution | WB~~1:500~1000 E~~N/A |
Format | Clear, colorless solution in phosphate buffered saline, pH 7.2 . |
Storage | Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing. |
Precautions | PLXDC1 Antibody (monoclonal) (M01) is for research use only and not for use in diagnostic or therapeutic procedures. |
For Research Use Only. Not For Use In Diagnostic Procedures.
Provided below are standard protocols that you may find useful for product applications.
REFERENCES
Personalized smoking cessation: interactions between nicotine dose, dependence and quit-success genotype score. Rose JE, et al. Mol Med, 2010 Jul-Aug. PMID 20379614.Preferential expression of the secreted and membrane forms of tumor endothelial marker 7 transcripts in osteosarcoma. Halder C, et al. Anticancer Res, 2009 Nov. PMID 20032373.TEM7 (PLXDC1) in neovascular endothelial cells of fibrovascular membranes from patients with proliferative diabetic retinopathy. Yamaji Y, et al. Invest Ophthalmol Vis Sci, 2008 Jul. PMID 18316703.High expression of tumor endothelial marker 7 is associated with metastasis and poor survival of patients with osteogenic sarcoma. Fuchs B, et al. Gene, 2007 Sep 15. PMID 17560052.Identification of the basement membrane protein nidogen as a candidate ligand for tumor endothelial marker 7 in vitro and in vivo. Lee HK, et al. FEBS Lett, 2006 Apr 17. PMID 16574105.

终于等到您。ABCEPTA(百远生物)抗体产品。
点击下方“我要评价 ”按钮提交您的反馈信息,您的反馈和评价是我们最宝贵的财富之一,
我们将在1-3个工作日内处理您的反馈信息。
如有疑问,联系:0512-88856768 tech-china@abcepta.com.